NorthShore University HealthSystem
NorthShore University HealthSystem
Evanston, Illinois, United States25 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Precision-Based Genomics in Prostate Cancer | Disease Attributes, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, disease susceptibility, inherited disease susceptibility, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Not stated | 2026-10-08 | NCT04706663 | |
| A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer | Low Grade Serous Ovarian Cancer | Recruiting | Phase 3 | 2026-10-07 | NCT06072781 | |
| The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-30 | NCT05836987 | |
| A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT05702034 | |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 3 | 2026-09-09 | NCT05633654 | |
| A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-09-03 | NCT07005154 | |
| Prenatal Sonographic Prediction of Placental Histology and Function | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, pregnancy disorder | Recruiting | Not stated | 2026-07-23 | NCT06022458 | |
| Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project | Abortion, Spontaneous, Death, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Premature Birth, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder, pregnancy disorder with abortive outcome | Recruiting | Phase 2 | 2026-07-23 | NCT06004674 | |
| Pancreatic Cancer Early Detection Consortium | Cysts, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasms by Site, Pancreatic Cyst, Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease susceptibility, endocrine system disorder, inherited disease susceptibility, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Recruiting | Not stated | 2026-07-22 | NCT04970056 | |
| A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 2 | 2026-02-10 | NCT06190951 | |
| A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, nephritis, urinary system disorder | Recruiting | Phase 3 | 2026-02-03 | NCT05183646 | |
| Ribociclib and Letrozole Treatment in Ovarian Cancer | Cystadenocarcinoma, Serous, Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystadenocarcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, neoplasm | Active, not recruiting | Phase 2 | 2025-12-23 | NCT03673124 | |
| Quality Improvement and Practice Based Research in Neurology Using the EMR | Brain Concussion, Brain Injuries, Traumatic, CNS demyelinating autoimmune disease, Cognition Disorders, Cognitive Dysfunction, Craniocerebral Trauma, Dyssomnias, Head Injuries, Closed, Mild Cognitive Impairment, Neoplasms by Site, Parasomnias, Parkinson disease, Sleep Disorders, Intrinsic, Wounds, Nonpenetrating, autoimmune disease, autoimmune disorder of the nervous system, basal ganglia disorder, brain cancer, brain disorder, brain injury, cardiovascular disorder, central nervous system cancer, central nervous system disorder, cerebrovascular disorder, cognitive disorder, demyelinating disease, epilepsy, headache disorder, hypnic headache, immune system disorder, injury, migraine disorder, movement disorder, multiple sclerosis, neoplasm, nervous system disorder, nervous system injury, neurodegenerative disease, parkinsonian disorder, peripheral neuropathy, psychiatric disorder, restless legs syndrome, sleep-wake disorder, stroke disorder, synucleinopathy, vascular disorder | Enrolling by invitation | Phase 4 | 2025-08-24 | NCT02670161 | |
| Non Inferiority Trial Investigating Surfactants Administered Via MIST | Respiration Disorders, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Recruiting | Phase 4 | 2025-08-07 | NCT06074380 | |
| Prophylactic Minimally Invasive Surfactant Evaluation | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Infant, Premature, Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Respiration Disorders, Respiratory Distress Syndrome, Newborn, Urogenital Diseases, adult acute respiratory distress syndrome, lung disorder, pregnancy disorder, respiratory system disorder | Recruiting | Phase 4 | 2025-08-07 | NCT06007547 | |
| Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 2 | 2025-06-10 | NCT02788981 | |
| Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 2 | 2025-06-10 | NCT02743819 | |
| Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD | CNS demyelinating autoimmune disease, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis | Recruiting | Not applicable | 2025-04-10 | NCT05566769 | |
| TRILUMINATE Pivotal Trial | cardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiency | Active, not recruiting | Not applicable | 2024-12-19 | NCT03904147 | |
| Fundoplication in Laparoscopic PEH Repair Based on FLIP | Deglutition Disorders, Digestive System Diseases, Hernia, Hernia, Diaphragmatic, Internal Hernia, Paraesophageal Hiatal Hernia, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, digestive system disorder, dyskinesia of esophagus, esophageal disorder, gastroesophageal reflux disease, hiatus hernia | Enrolling by invitation | Not applicable | 2024-11-27 | NCT05807763 | |
| PARTNER 3 Trial - Aortic Valve-in-Valve | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not applicable | 2024-05-10 | NCT03003299 | |
| Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Not yet recruiting | Not applicable | 2024-05-07 | NCT05921149 | |
| Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, intestinal disorder, microscopic colitis | Recruiting | Phase 2 | 2021-04-15 | NCT04043897 | |
| Methadone and Quality of Postoperative Recovery | Quality of Recovery Scores | Recruiting | Phase 4 | 2020-08-24 | NCT03168958 | |
| Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery | EKG-QT Prolongation | Recruiting | Phase 4 | 2019-09-13 | NCT03893734 |